Shihai Gu

Title: Shihai Gu: Innovator in Protein Kinase C Inhibitors

Introduction

Shihai Gu is a prominent inventor based in Union City, CA, known for his significant contributions to the field of pharmaceutical sciences. He holds three patents that focus on innovative compounds aimed at treating various diseases and disorders.

Latest Patents

One of his latest patents is titled "Protein kinase C inhibitors and uses thereof." This disclosure concerns compounds that serve as inhibitors of protein kinase C (PKC), which are useful for treating a variety of diseases and disorders mediated or sustained through the activity of PKC. The patent also relates to pharmaceutical compositions comprising these compounds, methods of using them in treatment, and processes for preparing these compounds and their intermediates. Another notable patent is "Cyclic amine substituted pyrimidinediamines as PKC inhibitors." This invention encompasses compounds with specific formulas and the compositions and methods for using these compounds in treating conditions where inhibition of PKC and PKD is therapeutically beneficial.

Career Highlights

Shihai Gu is currently associated with Rigel Pharmaceuticals, Incorporated, where he continues to advance his research and development efforts in the pharmaceutical industry. His work has been instrumental in creating innovative solutions for complex medical challenges.

Collaborations

He collaborates with talented individuals such as Rajinder Paul Singh and Haoran Zhao, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Shihai Gu's work in developing protein kinase C inhibitors showcases his commitment to advancing medical science and improving patient outcomes. His contributions are vital in the ongoing quest for effective treatments for various diseases.